agence france-presse
click here to return to agence france-presse main menu
DonateNow



HIV-positive Ivorians to receive free anti-retroviral treatment

Agence France-Presse - August 29, 2008


ABIDJAN, Aug 29, 2008 (AFP) - Ivorians with HIV/AIDS can now get free anti-retroviral treatment in public health centers with foreign funders picking up much of the tab, according to a decree of which AFP obtained a copy Friday.

"Antiretroviral treatment is free in all public health establishments," said the decree signed by Health Minister Remi Allah Kouadio, which took effect August 20.

Most of the treatment costs will be paid for by the US government's emergency plan for AIDS relief (PEPFAR) and the Geneva-based Global Fund to fight AIDS, Tuberculosis and Malaria.

The two have earmarked 19 million dollars (13 millions euros) and seven million dollars respectively for AIDS relief over the 2008-2009 period, said Toussaint Sibailly, the doctor in charge of the PEPFAR programme here.

The Ivorian government is investing one billion CFA francs (two million dollars) into the project.

Funders hope to treat 77,000 people during the first period, rising to 104,000 by 2010, Sibailly said.

Roughly 4.7 percent of people are HIV-positive in the west African country, according to a 2005-2006 national survey, translating to about 750,000 people of which about a seventh are eligible for anti-retroviral treatment.

080829
AF080867


Copyright ©AFP 2008. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics.  http://www.afp.com/

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.